We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BERY
1051
DELISTED
Berry Global Group, Inc.
BERY
| $9.32M | 0.01% |
155,605
-6,958
| -4% | -$419K |
|
1052
Arcosa
ACA
$7.14B
| $9.31M | 0.01% |
158,554
-6,914
| -4% | -$428K |
|
1053
Kennametal
KMT
$2.6B
| $9.31M | 0.01% |
259,219
-9,872
| -4% | -$386K |
|
1054
Brady Corp
BRC
$4.62B
| $9.28M | 0.01% |
165,568
+10,815
| +7% | +$608K |
|
1055
Group 1 Automotive
GPI
$3.31B
| $9.27M | 0.01% |
60,022
-2,137
| -3% | -$343K |
|
1056
Prestige Consumer Healthcare
PBH
$2.51B
| $9.27M | 0.01% |
177,845
+3,324
| +2% | +$160K |
|
1057
CNX Resources
CNX
$5.11B
| $9.26M | 0.01% |
677,711
-19,928
| -3% | -$279K |
|
1058
Kinsale Capital Group
KNSL
$8.45B
| $9.24M | 0.01% |
56,079
-466
| -0.8% | -$76.9K |
|
1059
Ralph Lauren
RL
$22.7B
| $9.24M | 0.01% |
78,428
-5,102
| -6% | -$639K |
|
1060
MillerKnoll
MLKN
$1.63B
| $9.24M | 0.01% |
195,945
-7,201
| -4% | -$326K |
|
|
NVTA
1061
DELISTED
Invitae Corporation
NVTA
| $9.23M | 0.01% |
273,530
+130,733
| +92% | +$4.25M |
|
1062
Perrigo
PRGO
$1.84B
| $9.15M | 0.01% |
199,541
-16,648
| -8% | -$738K |
|
1063
Albany International
AIN
$1.75B
| $9.13M | 0.01% |
102,339
+4,794
| +5% | +$420K |
|
1064
Qualys
QLYS
$6.45B
| $9.13M | 0.01% |
90,714
-1,123
| -1% | -$114K |
|
1065
Clarivate
CLVT
$1.24B
| $9.12M | 0.01% |
+331,255
| New | +$9.1M |
|
1066
Emergent Biosolutions
EBS
$389M
| $9.11M | 0.01% |
144,670
+20,617
| +17% | +$1.32M |
|
1067
Merit Medical Systems
MMSI
$5.21B
| $9.11M | 0.01% |
140,874
-3,569
| -2% | -$221K |
|
1068
Insperity
NSP
$1.95B
| $9.11M | 0.01% |
100,755
-9,555
| -9% | -$853K |
|
|
UFS
1069
DELISTED
DOMTAR CORPORATION (New)
UFS
| $9.05M | 0.01% |
164,747
-10,712
| -6% | -$518K |
|
1070
Quaker Houghton
KWR
$2.94B
| $9.04M | 0.01% |
38,125
-756
| -2% | -$181K |
|
1071
Visteon
VC
$2.79B
| $9.04M | 0.01% |
74,739
-1,574
| -2% | -$189K |
|
1072
CVB Financial
CVBF
$4.03B
| $9.03M | 0.01% |
438,655
-16,984
| -4% | -$371K |
|
1073
Minerals Technologies
MTX
$2.4B
| $9.03M | 0.01% |
114,730
-5,113
| -4% | -$413K |
|
|
ACH
1074
Accendra Health
ACH
$227M
| $8.99M | 0.01% |
212,375
-32,444
| -13% | -$1.26M |
|
1075
Upbound Group
UPBD
$1.17B
| $8.99M | 0.01% |
169,384
+30,015
| +22% | +$1.74M |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.